nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.322	1	CrCtD
Progesterone—PGR—uterine cancer	0.0946	0.613	CbGaD
Progesterone—ESR1—uterine cancer	0.0597	0.387	CbGaD
Progesterone—PGR—Medroxyprogesterone Acetate—uterine cancer	0.0354	0.177	CbGbCtD
Progesterone—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.0339	0.17	CbGbCtD
Progesterone—AR—Medroxyprogesterone Acetate—uterine cancer	0.0284	0.142	CbGbCtD
Progesterone—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0245	0.123	CbGbCtD
Progesterone—Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.0218	0.0987	CrCrCtD
Progesterone—Ethynodiol—Medroxyprogesterone Acetate—uterine cancer	0.0204	0.0926	CrCrCtD
Progesterone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0181	0.0906	CbGbCtD
Progesterone—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.0173	0.0784	CrCrCtD
Progesterone—Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.0173	0.0784	CrCrCtD
Progesterone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.0165	0.0747	CrCrCtD
Progesterone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.0165	0.0747	CrCrCtD
Progesterone—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.0151	0.0684	CrCrCtD
Progesterone—Medrysone—Medroxyprogesterone Acetate—uterine cancer	0.0139	0.0631	CrCrCtD
Progesterone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.0121	0.0549	CrCrCtD
Progesterone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.0117	0.0532	CrCrCtD
Progesterone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0105	0.0474	CrCrCtD
Progesterone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0462	CrCrCtD
Progesterone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0462	CrCrCtD
Progesterone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.00994	0.0451	CrCrCtD
Progesterone—ABCC1—Dactinomycin—uterine cancer	0.00916	0.0459	CbGbCtD
Progesterone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.00885	0.0401	CrCrCtD
Progesterone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00832	0.0377	CrCrCtD
Progesterone—ABCC1—Epirubicin—uterine cancer	0.00663	0.0333	CbGbCtD
Progesterone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.00621	0.0312	CbGbCtD
Progesterone—ABCC1—Etoposide—uterine cancer	0.00517	0.0259	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—uterine cancer	0.00496	0.0249	CbGbCtD
Progesterone—ABCB11—Doxorubicin—uterine cancer	0.00496	0.0249	CbGbCtD
Progesterone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.00433	0.0217	CbGbCtD
Progesterone—ABCC1—Doxorubicin—uterine cancer	0.00352	0.0177	CbGbCtD
Progesterone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.0126	CbGbCtD
Progesterone—ABCB1—Dactinomycin—uterine cancer	0.00221	0.0111	CbGbCtD
Progesterone—PGR—corpus luteum—uterine cancer	0.00197	0.0865	CbGeAlD
Progesterone—CYP3A5—Etoposide—uterine cancer	0.00192	0.00961	CbGbCtD
Progesterone—CYP2C8—Etoposide—uterine cancer	0.00184	0.00924	CbGbCtD
Progesterone—CYP1A2—Etoposide—uterine cancer	0.00143	0.00715	CbGbCtD
Progesterone—ABCB1—Etoposide—uterine cancer	0.00125	0.00626	CbGbCtD
Progesterone—SHBG—semen—uterine cancer	0.00103	0.045	CbGeAlD
Progesterone—ABCB1—Doxorubicin—uterine cancer	0.00085	0.00427	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—uterine cancer	0.000801	0.00402	CbGbCtD
Progesterone—CYP3A4—Etoposide—uterine cancer	0.000747	0.00375	CbGbCtD
Progesterone—AR—semen—uterine cancer	0.000737	0.0323	CbGeAlD
Progesterone—PGR—oviduct—uterine cancer	0.000679	0.0297	CbGeAlD
Progesterone—AR—oviduct—uterine cancer	0.000541	0.0237	CbGeAlD
Progesterone—ESR1—oviduct—uterine cancer	0.000531	0.0233	CbGeAlD
Progesterone—CYP3A4—Doxorubicin—uterine cancer	0.00051	0.00256	CbGbCtD
Progesterone—PGR—artery—uterine cancer	0.000449	0.0197	CbGeAlD
Progesterone—Finasteride—SRD5A2—uterine cancer	0.00032	0.149	CrCbGaD
Progesterone—SLC10A1—renal system—uterine cancer	0.00027	0.0118	CbGeAlD
Progesterone—CYP17A1—renal system—uterine cancer	0.000235	0.0103	CbGeAlD
Progesterone—NR3C2—myometrium—uterine cancer	0.000234	0.0102	CbGeAlD
Progesterone—PGR—myometrium—uterine cancer	0.000217	0.00951	CbGeAlD
Progesterone—SLC10A1—female reproductive system—uterine cancer	0.000216	0.00948	CbGeAlD
Progesterone—SLC22A2—renal system—uterine cancer	0.000214	0.00939	CbGeAlD
Progesterone—SLC22A3—myometrium—uterine cancer	0.000199	0.00871	CbGeAlD
Progesterone—SIGMAR1—myometrium—uterine cancer	0.000192	0.00842	CbGeAlD
Progesterone—OPRK1—female reproductive system—uterine cancer	0.000191	0.00835	CbGeAlD
Progesterone—CYP17A1—female reproductive system—uterine cancer	0.000188	0.00826	CbGeAlD
Progesterone—NR3C2—uterine cervix—uterine cancer	0.000182	0.00796	CbGeAlD
Progesterone—NR3C2—smooth muscle tissue—uterine cancer	0.000177	0.00774	CbGeAlD
Progesterone—AR—myometrium—uterine cancer	0.000173	0.00758	CbGeAlD
Progesterone—CYP17A1—female gonad—uterine cancer	0.000172	0.00751	CbGeAlD
Progesterone—PGR—epithelium—uterine cancer	0.00017	0.00747	CbGeAlD
Progesterone—NR3C2—renal system—uterine cancer	0.00017	0.00745	CbGeAlD
Progesterone—ESR1—myometrium—uterine cancer	0.00017	0.00744	CbGeAlD
Progesterone—SHBG—endometrium—uterine cancer	0.00017	0.00743	CbGeAlD
Progesterone—PGR—uterine cervix—uterine cancer	0.000169	0.0074	CbGeAlD
Progesterone—NR3C2—endometrium—uterine cancer	0.000164	0.0072	CbGeAlD
Progesterone—ABCC1—myometrium—uterine cancer	0.000164	0.0072	CbGeAlD
Progesterone—PGR—smooth muscle tissue—uterine cancer	0.000164	0.00719	CbGeAlD
Progesterone—PGR—decidua—uterine cancer	0.000161	0.00705	CbGeAlD
Progesterone—NR3C2—mammalian vulva—uterine cancer	0.000159	0.00697	CbGeAlD
Progesterone—SHBG—uterus—uterine cancer	0.000156	0.00685	CbGeAlD
Progesterone—SLC22A3—uterine cervix—uterine cancer	0.000155	0.00678	CbGeAlD
Progesterone—PGR—endometrium—uterine cancer	0.000153	0.0067	CbGeAlD
Progesterone—NR3C2—uterus—uterine cancer	0.000151	0.00664	CbGeAlD
Progesterone—SLC22A1—renal system—uterine cancer	0.000151	0.00663	CbGeAlD
Progesterone—SLC22A3—smooth muscle tissue—uterine cancer	0.00015	0.00658	CbGeAlD
Progesterone—SIGMAR1—uterine cervix—uterine cancer	0.000149	0.00655	CbGeAlD
Progesterone—SIGMAR1—smooth muscle tissue—uterine cancer	0.000145	0.00637	CbGeAlD
Progesterone—SLC22A3—renal system—uterine cancer	0.000145	0.00634	CbGeAlD
Progesterone—SIGMAR1—decidua—uterine cancer	0.000142	0.00624	CbGeAlD
Progesterone—PGR—uterus—uterine cancer	0.000141	0.00617	CbGeAlD
Progesterone—SHBG—female reproductive system—uterine cancer	0.000141	0.00616	CbGeAlD
Progesterone—SLC22A3—endometrium—uterine cancer	0.00014	0.00613	CbGeAlD
Progesterone—CYP1B1—smooth muscle tissue—uterine cancer	0.000138	0.00605	CbGeAlD
Progesterone—Dydrogesterone—PGR—uterine cancer	0.000137	0.0641	CrCbGaD
Progesterone—NR3C2—female reproductive system—uterine cancer	0.000136	0.00597	CbGeAlD
Progesterone—AR—epithelium—uterine cancer	0.000136	0.00595	CbGeAlD
Progesterone—CYP1B1—decidua—uterine cancer	0.000135	0.00593	CbGeAlD
Progesterone—SLC22A3—mammalian vulva—uterine cancer	0.000135	0.00593	CbGeAlD
Progesterone—SIGMAR1—endometrium—uterine cancer	0.000135	0.00592	CbGeAlD
Progesterone—AR—uterine cervix—uterine cancer	0.000135	0.0059	CbGeAlD
Progesterone—ESR1—epithelium—uterine cancer	0.000133	0.00584	CbGeAlD
Progesterone—CYP1B1—renal system—uterine cancer	0.000133	0.00583	CbGeAlD
Progesterone—ESR1—uterine cervix—uterine cancer	0.000132	0.00579	CbGeAlD
Progesterone—CYP2A6—vagina—uterine cancer	0.000131	0.00576	CbGeAlD
Progesterone—AR—smooth muscle tissue—uterine cancer	0.000131	0.00573	CbGeAlD
Progesterone—SIGMAR1—mammalian vulva—uterine cancer	0.000131	0.00573	CbGeAlD
Progesterone—ESR1—smooth muscle tissue—uterine cancer	0.000128	0.00563	CbGeAlD
Progesterone—AR—decidua—uterine cancer	0.000128	0.00562	CbGeAlD
Progesterone—SHBG—female gonad—uterine cancer	0.000128	0.0056	CbGeAlD
Progesterone—ABCC1—uterine cervix—uterine cancer	0.000128	0.0056	CbGeAlD
Progesterone—SHBG—vagina—uterine cancer	0.000127	0.00557	CbGeAlD
Progesterone—PGR—female reproductive system—uterine cancer	0.000127	0.00555	CbGeAlD
Progesterone—AR—renal system—uterine cancer	0.000126	0.00552	CbGeAlD
Progesterone—ESR1—decidua—uterine cancer	0.000126	0.00552	CbGeAlD
Progesterone—NR3C1—myometrium—uterine cancer	0.000125	0.00549	CbGeAlD
Progesterone—SIGMAR1—uterus—uterine cancer	0.000125	0.00546	CbGeAlD
Progesterone—NR3C2—female gonad—uterine cancer	0.000124	0.00543	CbGeAlD
Progesterone—ESR1—renal system—uterine cancer	0.000124	0.00542	CbGeAlD
Progesterone—NR3C2—vagina—uterine cancer	0.000123	0.0054	CbGeAlD
Progesterone—ABCC1—decidua—uterine cancer	0.000122	0.00534	CbGeAlD
Progesterone—AR—endometrium—uterine cancer	0.000122	0.00533	CbGeAlD
Progesterone—ESR1—endometrium—uterine cancer	0.00012	0.00524	CbGeAlD
Progesterone—CYP1B1—uterus—uterine cancer	0.000118	0.00519	CbGeAlD
Progesterone—AR—mammalian vulva—uterine cancer	0.000118	0.00516	CbGeAlD
Progesterone—SLC22A3—female reproductive system—uterine cancer	0.000116	0.00508	CbGeAlD
Progesterone—ABCC1—endometrium—uterine cancer	0.000116	0.00507	CbGeAlD
Progesterone—PGR—female gonad—uterine cancer	0.000115	0.00505	CbGeAlD
Progesterone—PGR—vagina—uterine cancer	0.000114	0.00502	CbGeAlD
Progesterone—Ethynodiol—PGR—uterine cancer	0.000113	0.0528	CrCbGaD
Progesterone—AR—uterus—uterine cancer	0.000112	0.00492	CbGeAlD
Progesterone—ABCC1—mammalian vulva—uterine cancer	0.000112	0.0049	CbGeAlD
Progesterone—CYP17A1—lymph node—uterine cancer	0.00011	0.00483	CbGeAlD
Progesterone—ESR1—uterus—uterine cancer	0.00011	0.00483	CbGeAlD
Progesterone—SLC22A1—vagina—uterine cancer	0.00011	0.0048	CbGeAlD
Progesterone—Trilostane—ESR2—uterine cancer	0.000107	0.0498	CrCbGaD
Progesterone—ABCC1—uterus—uterine cancer	0.000107	0.00467	CbGeAlD
Progesterone—CYP1B1—female reproductive system—uterine cancer	0.000107	0.00467	CbGeAlD
Progesterone—SLC22A3—female gonad—uterine cancer	0.000105	0.00462	CbGeAlD
Progesterone—SLC22A3—vagina—uterine cancer	0.000105	0.00459	CbGeAlD
Progesterone—SIGMAR1—female gonad—uterine cancer	0.000102	0.00447	CbGeAlD
Progesterone—CYP2C8—renal system—uterine cancer	0.000102	0.00446	CbGeAlD
Progesterone—CYP1A1—epithelium—uterine cancer	0.000101	0.00444	CbGeAlD
Progesterone—SIGMAR1—vagina—uterine cancer	0.000101	0.00444	CbGeAlD
Progesterone—AR—female reproductive system—uterine cancer	0.000101	0.00442	CbGeAlD
Progesterone—CYP1A1—uterine cervix—uterine cancer	0.0001	0.0044	CbGeAlD
Progesterone—ESR1—female reproductive system—uterine cancer	9.9e-05	0.00434	CbGeAlD
Progesterone—CYP2C8—endometrium—uterine cancer	9.85e-05	0.00431	CbGeAlD
Progesterone—NR3C1—epithelium—uterine cancer	9.83e-05	0.00431	CbGeAlD
Progesterone—CYP3A5—uterine cervix—uterine cancer	9.83e-05	0.0043	CbGeAlD
Progesterone—NR3C1—uterine cervix—uterine cancer	9.75e-05	0.00427	CbGeAlD
Progesterone—CYP1B1—female gonad—uterine cancer	9.69e-05	0.00425	CbGeAlD
Progesterone—Norgestimate—PGR—uterine cancer	9.62e-05	0.0449	CrCbGaD
Progesterone—CYP1A2—renal system—uterine cancer	9.53e-05	0.00418	CbGeAlD
Progesterone—NR3C1—smooth muscle tissue—uterine cancer	9.48e-05	0.00415	CbGeAlD
Progesterone—CYP1A1—renal system—uterine cancer	9.4e-05	0.00412	CbGeAlD
Progesterone—NR3C1—decidua—uterine cancer	9.29e-05	0.00407	CbGeAlD
Progesterone—CYP3A5—renal system—uterine cancer	9.19e-05	0.00403	CbGeAlD
Progesterone—AR—female gonad—uterine cancer	9.18e-05	0.00402	CbGeAlD
Progesterone—AR—vagina—uterine cancer	9.12e-05	0.004	CbGeAlD
Progesterone—NR3C1—renal system—uterine cancer	9.12e-05	0.004	CbGeAlD
Progesterone—ESR1—female gonad—uterine cancer	9.01e-05	0.00395	CbGeAlD
Progesterone—ESR1—vagina—uterine cancer	8.96e-05	0.00392	CbGeAlD
Progesterone—NR3C1—endometrium—uterine cancer	8.82e-05	0.00386	CbGeAlD
Progesterone—Danazol—CCL2—uterine cancer	8.81e-05	0.0411	CrCbGaD
Progesterone—CYP1A1—mammalian vulva—uterine cancer	8.79e-05	0.00385	CbGeAlD
Progesterone—ABCC1—female gonad—uterine cancer	8.72e-05	0.00382	CbGeAlD
Progesterone—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	8.67e-05	0.0404	CrCbGaD
Progesterone—ABCC1—vagina—uterine cancer	8.66e-05	0.0038	CbGeAlD
Progesterone—NR3C1—mammalian vulva—uterine cancer	8.53e-05	0.00374	CbGeAlD
Progesterone—CYP2C19—vagina—uterine cancer	8.45e-05	0.0037	CbGeAlD
Progesterone—CYP1A1—uterus—uterine cancer	8.38e-05	0.00367	CbGeAlD
Progesterone—Megestrol acetate—PGR—uterine cancer	8.27e-05	0.0386	CrCbGaD
Progesterone—CYP2C8—female reproductive system—uterine cancer	8.16e-05	0.00357	CbGeAlD
Progesterone—NR3C1—uterus—uterine cancer	8.13e-05	0.00356	CbGeAlD
Progesterone—Nandrolone phenpropionate—CYP19A1—uterine cancer	8.02e-05	0.0374	CrCbGaD
Progesterone—NR3C2—lymph node—uterine cancer	7.97e-05	0.00349	CbGeAlD
Progesterone—Testolactone—CYP19A1—uterine cancer	7.65e-05	0.0357	CrCbGaD
Progesterone—CYP1A1—female reproductive system—uterine cancer	7.53e-05	0.0033	CbGeAlD
Progesterone—PGR—lymph node—uterine cancer	7.41e-05	0.00324	CbGeAlD
Progesterone—CYP2C8—vagina—uterine cancer	7.38e-05	0.00323	CbGeAlD
Progesterone—NR3C1—female reproductive system—uterine cancer	7.31e-05	0.0032	CbGeAlD
Progesterone—CYP2C9—female reproductive system—uterine cancer	7.25e-05	0.00317	CbGeAlD
Progesterone—Drospirenone—PGR—uterine cancer	7.22e-05	0.0337	CrCbGaD
Progesterone—Ethynodiol—ESR1—uterine cancer	7.15e-05	0.0333	CrCbGaD
Progesterone—CYP3A4—renal system—uterine cancer	6.9e-05	0.00302	CbGeAlD
Progesterone—CYP1A1—female gonad—uterine cancer	6.85e-05	0.003	CbGeAlD
Progesterone—Drostanolone—CYP19A1—uterine cancer	6.82e-05	0.0318	CrCbGaD
Progesterone—CYP1A1—vagina—uterine cancer	6.81e-05	0.00298	CbGeAlD
Progesterone—CYP2D6—renal system—uterine cancer	6.79e-05	0.00297	CbGeAlD
Progesterone—SLC22A3—lymph node—uterine cancer	6.78e-05	0.00297	CbGeAlD
Progesterone—ABCB1—myometrium—uterine cancer	6.71e-05	0.00294	CbGeAlD
Progesterone—CYP3A5—female gonad—uterine cancer	6.7e-05	0.00293	CbGeAlD
Progesterone—CYP3A5—vagina—uterine cancer	6.66e-05	0.00292	CbGeAlD
Progesterone—NR3C1—female gonad—uterine cancer	6.65e-05	0.00291	CbGeAlD
Progesterone—NR3C1—vagina—uterine cancer	6.61e-05	0.00289	CbGeAlD
Progesterone—Trilostane—ESR1—uterine cancer	6.58e-05	0.0307	CrCbGaD
Progesterone—SIGMAR1—lymph node—uterine cancer	6.55e-05	0.00287	CbGeAlD
Progesterone—CYP1B1—lymph node—uterine cancer	6.23e-05	0.00273	CbGeAlD
Progesterone—Nandrolone decanoate—CYP19A1—uterine cancer	6.08e-05	0.0283	CrCbGaD
Progesterone—Norgestimate—ESR1—uterine cancer	6.08e-05	0.0283	CrCbGaD
Progesterone—AR—lymph node—uterine cancer	5.9e-05	0.00258	CbGeAlD
Progesterone—Levonorgestrel—PGR—uterine cancer	5.89e-05	0.0275	CrCbGaD
Progesterone—ESR1—lymph node—uterine cancer	5.79e-05	0.00254	CbGeAlD
Progesterone—ABCC1—lymph node—uterine cancer	5.6e-05	0.00246	CbGeAlD
Progesterone—CYP3A4—female reproductive system—uterine cancer	5.52e-05	0.00242	CbGeAlD
Progesterone—CYP2D6—female reproductive system—uterine cancer	5.44e-05	0.00238	CbGeAlD
Progesterone—Danazol—PGR—uterine cancer	5.37e-05	0.025	CrCbGaD
Progesterone—ABCB1—epithelium—uterine cancer	5.26e-05	0.00231	CbGeAlD
Progesterone—ABCB1—uterine cervix—uterine cancer	5.22e-05	0.00229	CbGeAlD
Progesterone—Spironolactone—PGR—uterine cancer	5.14e-05	0.024	CrCbGaD
Progesterone—ABCB1—decidua—uterine cancer	4.97e-05	0.00218	CbGeAlD
Progesterone—CYP2D6—female gonad—uterine cancer	4.95e-05	0.00217	CbGeAlD
Progesterone—ABCB1—renal system—uterine cancer	4.88e-05	0.00214	CbGeAlD
Progesterone—Medroxyprogesterone Acetate—PGR—uterine cancer	4.82e-05	0.0225	CrCbGaD
Progesterone—Norethindrone—PGR—uterine cancer	4.77e-05	0.0223	CrCbGaD
Progesterone—ABCB1—endometrium—uterine cancer	4.72e-05	0.00207	CbGeAlD
Progesterone—ABCB1—mammalian vulva—uterine cancer	4.57e-05	0.002	CbGeAlD
Progesterone—CYP1A1—lymph node—uterine cancer	4.4e-05	0.00193	CbGeAlD
Progesterone—ABCB1—uterus—uterine cancer	4.35e-05	0.00191	CbGeAlD
Progesterone—NR3C1—lymph node—uterine cancer	4.27e-05	0.00187	CbGeAlD
Progesterone—Levonorgestrel—CYP19A1—uterine cancer	4.04e-05	0.0188	CrCbGaD
Progesterone—ABCB1—female reproductive system—uterine cancer	3.91e-05	0.00171	CbGeAlD
Progesterone—Levonorgestrel—ESR1—uterine cancer	3.72e-05	0.0173	CrCbGaD
Progesterone—Danazol—CYP19A1—uterine cancer	3.68e-05	0.0172	CrCbGaD
Progesterone—ABCB1—female gonad—uterine cancer	3.56e-05	0.00156	CbGeAlD
Progesterone—Fluoxymesterone—ESR1—uterine cancer	3.54e-05	0.0165	CrCbGaD
Progesterone—ABCB1—vagina—uterine cancer	3.54e-05	0.00155	CbGeAlD
Progesterone—Testosterone—CYP11A1—uterine cancer	3.49e-05	0.0163	CrCbGaD
Progesterone—Danazol—ESR1—uterine cancer	3.39e-05	0.0158	CrCbGaD
Progesterone—Methyltestosterone—CYP19A1—uterine cancer	3.11e-05	0.0145	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—ESR1—uterine cancer	3.04e-05	0.0142	CrCbGaD
Progesterone—Hypersensitivity—Dactinomycin—uterine cancer	2.69e-05	0.000508	CcSEcCtD
Progesterone—Gastritis—Epirubicin—uterine cancer	2.67e-05	0.000504	CcSEcCtD
Progesterone—Confusional state—Etoposide—uterine cancer	2.67e-05	0.000503	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Epirubicin—uterine cancer	2.66e-05	0.000502	CcSEcCtD
Progesterone—Anaphylactic shock—Etoposide—uterine cancer	2.65e-05	0.000499	CcSEcCtD
Progesterone—Mood swings—Doxorubicin—uterine cancer	2.64e-05	0.000499	CcSEcCtD
Progesterone—Infection—Etoposide—uterine cancer	2.63e-05	0.000496	CcSEcCtD
Progesterone—Abdominal distension—Epirubicin—uterine cancer	2.63e-05	0.000495	CcSEcCtD
Progesterone—Asthenia—Dactinomycin—uterine cancer	2.62e-05	0.000495	CcSEcCtD
Progesterone—Asthma—Epirubicin—uterine cancer	2.61e-05	0.000492	CcSEcCtD
Progesterone—Dysphagia—Epirubicin—uterine cancer	2.61e-05	0.000492	CcSEcCtD
Progesterone—Tachycardia—Etoposide—uterine cancer	2.58e-05	0.000487	CcSEcCtD
Progesterone—Liver function test abnormal—Doxorubicin—uterine cancer	2.58e-05	0.000486	CcSEcCtD
Progesterone—Skin disorder—Etoposide—uterine cancer	2.57e-05	0.000485	CcSEcCtD
Progesterone—Hyperhidrosis—Etoposide—uterine cancer	2.56e-05	0.000483	CcSEcCtD
Progesterone—Angina pectoris—Epirubicin—uterine cancer	2.54e-05	0.000479	CcSEcCtD
Progesterone—Breast disorder—Doxorubicin—uterine cancer	2.52e-05	0.000476	CcSEcCtD
Progesterone—Anorexia—Etoposide—uterine cancer	2.52e-05	0.000476	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	2.51e-05	0.000474	CcSEcCtD
Progesterone—Bronchitis—Epirubicin—uterine cancer	2.51e-05	0.000473	CcSEcCtD
Progesterone—Diarrhoea—Dactinomycin—uterine cancer	2.5e-05	0.000472	CcSEcCtD
Progesterone—Nasopharyngitis—Doxorubicin—uterine cancer	2.5e-05	0.000471	CcSEcCtD
Progesterone—Hypotension—Etoposide—uterine cancer	2.47e-05	0.000466	CcSEcCtD
Progesterone—Gastritis—Doxorubicin—uterine cancer	2.47e-05	0.000466	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	2.46e-05	0.000465	CcSEcCtD
Progesterone—Dysuria—Epirubicin—uterine cancer	2.44e-05	0.00046	CcSEcCtD
Progesterone—Abdominal distension—Doxorubicin—uterine cancer	2.43e-05	0.000458	CcSEcCtD
Progesterone—Upper respiratory tract infection—Epirubicin—uterine cancer	2.42e-05	0.000457	CcSEcCtD
Progesterone—Dysphagia—Doxorubicin—uterine cancer	2.41e-05	0.000455	CcSEcCtD
Progesterone—Asthma—Doxorubicin—uterine cancer	2.41e-05	0.000455	CcSEcCtD
Progesterone—Pollakiuria—Epirubicin—uterine cancer	2.41e-05	0.000455	CcSEcCtD
Progesterone—Paraesthesia—Etoposide—uterine cancer	2.38e-05	0.000448	CcSEcCtD
Progesterone—Weight increased—Epirubicin—uterine cancer	2.37e-05	0.000448	CcSEcCtD
Progesterone—Weight decreased—Epirubicin—uterine cancer	2.36e-05	0.000445	CcSEcCtD
Progesterone—Dyspnoea—Etoposide—uterine cancer	2.36e-05	0.000445	CcSEcCtD
Progesterone—Hyperglycaemia—Epirubicin—uterine cancer	2.35e-05	0.000444	CcSEcCtD
Progesterone—Somnolence—Etoposide—uterine cancer	2.35e-05	0.000444	CcSEcCtD
Progesterone—Angina pectoris—Doxorubicin—uterine cancer	2.35e-05	0.000443	CcSEcCtD
Progesterone—Pneumonia—Epirubicin—uterine cancer	2.34e-05	0.000441	CcSEcCtD
Progesterone—Infestation—Epirubicin—uterine cancer	2.33e-05	0.000439	CcSEcCtD
Progesterone—Infestation NOS—Epirubicin—uterine cancer	2.33e-05	0.000439	CcSEcCtD
Progesterone—Drowsiness—Epirubicin—uterine cancer	2.33e-05	0.000439	CcSEcCtD
Progesterone—Vomiting—Dactinomycin—uterine cancer	2.32e-05	0.000439	CcSEcCtD
Progesterone—Bronchitis—Doxorubicin—uterine cancer	2.32e-05	0.000438	CcSEcCtD
Progesterone—Rash—Dactinomycin—uterine cancer	2.3e-05	0.000435	CcSEcCtD
Progesterone—Decreased appetite—Etoposide—uterine cancer	2.3e-05	0.000434	CcSEcCtD
Progesterone—ABCB1—lymph node—uterine cancer	2.29e-05	0.001	CbGeAlD
Progesterone—Gastrointestinal disorder—Etoposide—uterine cancer	2.28e-05	0.000431	CcSEcCtD
Progesterone—Fatigue—Etoposide—uterine cancer	2.28e-05	0.00043	CcSEcCtD
Progesterone—Neuropathy peripheral—Epirubicin—uterine cancer	2.28e-05	0.00043	CcSEcCtD
Progesterone—Jaundice—Epirubicin—uterine cancer	2.27e-05	0.000428	CcSEcCtD
Progesterone—Pain—Etoposide—uterine cancer	2.26e-05	0.000427	CcSEcCtD
Progesterone—Constipation—Etoposide—uterine cancer	2.26e-05	0.000427	CcSEcCtD
Progesterone—Conjunctivitis—Epirubicin—uterine cancer	2.26e-05	0.000426	CcSEcCtD
Progesterone—Urinary tract infection—Epirubicin—uterine cancer	2.26e-05	0.000426	CcSEcCtD
Progesterone—Dysuria—Doxorubicin—uterine cancer	2.26e-05	0.000426	CcSEcCtD
Progesterone—Upper respiratory tract infection—Doxorubicin—uterine cancer	2.24e-05	0.000423	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—uterine cancer	2.23e-05	0.000421	CcSEcCtD
Progesterone—Hepatobiliary disease—Epirubicin—uterine cancer	2.2e-05	0.000415	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—uterine cancer	2.2e-05	0.000414	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—uterine cancer	2.18e-05	0.000412	CcSEcCtD
Progesterone—Sinusitis—Epirubicin—uterine cancer	2.18e-05	0.000412	CcSEcCtD
Progesterone—Feeling abnormal—Etoposide—uterine cancer	2.18e-05	0.000411	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—uterine cancer	2.18e-05	0.000411	CcSEcCtD
Progesterone—Nausea—Dactinomycin—uterine cancer	2.17e-05	0.00041	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—uterine cancer	2.16e-05	0.000408	CcSEcCtD
Progesterone—Gastrointestinal pain—Etoposide—uterine cancer	2.16e-05	0.000408	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—uterine cancer	2.15e-05	0.000406	CcSEcCtD
Progesterone—Infestation—Doxorubicin—uterine cancer	2.15e-05	0.000406	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—uterine cancer	2.15e-05	0.000406	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—uterine cancer	2.11e-05	0.000398	CcSEcCtD
Progesterone—Urticaria—Etoposide—uterine cancer	2.1e-05	0.000397	CcSEcCtD
Progesterone—Haemoglobin—Epirubicin—uterine cancer	2.1e-05	0.000396	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—uterine cancer	2.1e-05	0.000396	CcSEcCtD
Progesterone—Rhinitis—Epirubicin—uterine cancer	2.09e-05	0.000395	CcSEcCtD
Progesterone—Body temperature increased—Etoposide—uterine cancer	2.09e-05	0.000395	CcSEcCtD
Progesterone—Abdominal pain—Etoposide—uterine cancer	2.09e-05	0.000395	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—uterine cancer	2.09e-05	0.000395	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—uterine cancer	2.09e-05	0.000395	CcSEcCtD
Progesterone—Haemorrhage—Epirubicin—uterine cancer	2.09e-05	0.000394	CcSEcCtD
Progesterone—Hepatitis—Epirubicin—uterine cancer	2.09e-05	0.000394	CcSEcCtD
Progesterone—Pharyngitis—Epirubicin—uterine cancer	2.07e-05	0.000391	CcSEcCtD
Progesterone—Urinary tract disorder—Epirubicin—uterine cancer	2.06e-05	0.000389	CcSEcCtD
Progesterone—Oedema peripheral—Epirubicin—uterine cancer	2.06e-05	0.000388	CcSEcCtD
Progesterone—Connective tissue disorder—Epirubicin—uterine cancer	2.05e-05	0.000387	CcSEcCtD
Progesterone—Urethral disorder—Epirubicin—uterine cancer	2.05e-05	0.000386	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—uterine cancer	2.03e-05	0.000384	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—uterine cancer	2.02e-05	0.000381	CcSEcCtD
Progesterone—Visual impairment—Epirubicin—uterine cancer	2.01e-05	0.00038	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—uterine cancer	1.97e-05	0.000372	CcSEcCtD
Progesterone—Eye disorder—Epirubicin—uterine cancer	1.95e-05	0.000368	CcSEcCtD
Progesterone—Hypersensitivity—Etoposide—uterine cancer	1.95e-05	0.000368	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—uterine cancer	1.95e-05	0.000367	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—uterine cancer	1.94e-05	0.000366	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—uterine cancer	1.94e-05	0.000366	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—uterine cancer	1.94e-05	0.000365	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—uterine cancer	1.93e-05	0.000364	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—uterine cancer	1.93e-05	0.000364	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—uterine cancer	1.92e-05	0.000362	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—uterine cancer	1.91e-05	0.00036	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—uterine cancer	1.9e-05	0.000359	CcSEcCtD
Progesterone—Asthenia—Etoposide—uterine cancer	1.9e-05	0.000358	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—uterine cancer	1.9e-05	0.000358	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—uterine cancer	1.89e-05	0.000357	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—uterine cancer	1.89e-05	0.000357	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—uterine cancer	1.89e-05	0.000356	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—uterine cancer	1.88e-05	0.000355	CcSEcCtD
Progesterone—Pruritus—Etoposide—uterine cancer	1.87e-05	0.000353	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—uterine cancer	1.86e-05	0.000351	CcSEcCtD
Progesterone—Alopecia—Epirubicin—uterine cancer	1.84e-05	0.000348	CcSEcCtD
Progesterone—Mental disorder—Epirubicin—uterine cancer	1.83e-05	0.000345	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—uterine cancer	1.83e-05	0.000345	CcSEcCtD
Progesterone—Erythema—Epirubicin—uterine cancer	1.82e-05	0.000343	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—uterine cancer	1.82e-05	0.000343	CcSEcCtD
Progesterone—Diarrhoea—Etoposide—uterine cancer	1.81e-05	0.000342	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—uterine cancer	1.8e-05	0.000341	CcSEcCtD
Progesterone—Testosterone—CYP19A1—uterine cancer	1.8e-05	0.00841	CrCbGaD
Progesterone—Tinnitus—Doxorubicin—uterine cancer	1.8e-05	0.00034	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—uterine cancer	1.79e-05	0.000338	CcSEcCtD
Progesterone—Flatulence—Epirubicin—uterine cancer	1.79e-05	0.000338	CcSEcCtD
Progesterone—Tension—Epirubicin—uterine cancer	1.78e-05	0.000336	CcSEcCtD
Progesterone—Nervousness—Epirubicin—uterine cancer	1.76e-05	0.000333	CcSEcCtD
Progesterone—Back pain—Epirubicin—uterine cancer	1.76e-05	0.000332	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—uterine cancer	1.75e-05	0.000331	CcSEcCtD
Progesterone—Dizziness—Etoposide—uterine cancer	1.75e-05	0.00033	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—uterine cancer	1.75e-05	0.00033	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—uterine cancer	1.74e-05	0.000329	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—uterine cancer	1.74e-05	0.000328	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—uterine cancer	1.71e-05	0.000323	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—uterine cancer	1.71e-05	0.000322	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—uterine cancer	1.69e-05	0.000319	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—uterine cancer	1.69e-05	0.000318	CcSEcCtD
Progesterone—Vomiting—Etoposide—uterine cancer	1.68e-05	0.000317	CcSEcCtD
Progesterone—Erythema—Doxorubicin—uterine cancer	1.68e-05	0.000317	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—uterine cancer	1.68e-05	0.000317	CcSEcCtD
Progesterone—Anaemia—Epirubicin—uterine cancer	1.68e-05	0.000317	CcSEcCtD
Progesterone—Rash—Etoposide—uterine cancer	1.67e-05	0.000315	CcSEcCtD
Progesterone—Dermatitis—Etoposide—uterine cancer	1.67e-05	0.000314	CcSEcCtD
Progesterone—Headache—Etoposide—uterine cancer	1.66e-05	0.000313	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—uterine cancer	1.66e-05	0.000313	CcSEcCtD
Progesterone—Tension—Doxorubicin—uterine cancer	1.65e-05	0.000311	CcSEcCtD
Progesterone—Malaise—Epirubicin—uterine cancer	1.64e-05	0.000309	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—uterine cancer	1.63e-05	0.000308	CcSEcCtD
Progesterone—Vertigo—Epirubicin—uterine cancer	1.63e-05	0.000308	CcSEcCtD
Progesterone—Syncope—Epirubicin—uterine cancer	1.63e-05	0.000307	CcSEcCtD
Progesterone—Back pain—Doxorubicin—uterine cancer	1.63e-05	0.000307	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—uterine cancer	1.62e-05	0.000305	CcSEcCtD
Progesterone—Palpitations—Epirubicin—uterine cancer	1.61e-05	0.000303	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—uterine cancer	1.6e-05	0.000301	CcSEcCtD
Progesterone—Cough—Epirubicin—uterine cancer	1.59e-05	0.000299	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—uterine cancer	1.58e-05	0.000299	CcSEcCtD
Progesterone—Convulsion—Epirubicin—uterine cancer	1.57e-05	0.000297	CcSEcCtD
Progesterone—Nausea—Etoposide—uterine cancer	1.57e-05	0.000296	CcSEcCtD
Progesterone—Hypertension—Epirubicin—uterine cancer	1.57e-05	0.000296	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—uterine cancer	1.56e-05	0.000294	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—uterine cancer	1.55e-05	0.000293	CcSEcCtD
Progesterone—Myalgia—Epirubicin—uterine cancer	1.55e-05	0.000292	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—uterine cancer	1.55e-05	0.000292	CcSEcCtD
Progesterone—Chest pain—Epirubicin—uterine cancer	1.55e-05	0.000292	CcSEcCtD
Progesterone—Anxiety—Epirubicin—uterine cancer	1.54e-05	0.000291	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	1.54e-05	0.00029	CcSEcCtD
Progesterone—Discomfort—Epirubicin—uterine cancer	1.53e-05	0.000288	CcSEcCtD
Progesterone—Malaise—Doxorubicin—uterine cancer	1.52e-05	0.000286	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—uterine cancer	1.51e-05	0.000285	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—uterine cancer	1.51e-05	0.000285	CcSEcCtD
Progesterone—Syncope—Doxorubicin—uterine cancer	1.51e-05	0.000284	CcSEcCtD
Progesterone—Confusional state—Epirubicin—uterine cancer	1.5e-05	0.000282	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—uterine cancer	1.49e-05	0.00028	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—uterine cancer	1.48e-05	0.00028	CcSEcCtD
Progesterone—Oedema—Epirubicin—uterine cancer	1.48e-05	0.00028	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—uterine cancer	1.48e-05	0.000279	CcSEcCtD
Progesterone—Infection—Epirubicin—uterine cancer	1.47e-05	0.000278	CcSEcCtD
Progesterone—Cough—Doxorubicin—uterine cancer	1.47e-05	0.000277	CcSEcCtD
Progesterone—Shock—Epirubicin—uterine cancer	1.46e-05	0.000275	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—uterine cancer	1.46e-05	0.000275	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—uterine cancer	1.45e-05	0.000274	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—uterine cancer	1.45e-05	0.000274	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—uterine cancer	1.45e-05	0.000273	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—uterine cancer	1.44e-05	0.000272	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—uterine cancer	1.43e-05	0.00027	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—uterine cancer	1.43e-05	0.00027	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—uterine cancer	1.43e-05	0.00027	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—uterine cancer	1.43e-05	0.00027	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—uterine cancer	1.43e-05	0.000269	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	1.42e-05	0.000268	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—uterine cancer	1.41e-05	0.000267	CcSEcCtD
Progesterone—Anorexia—Epirubicin—uterine cancer	1.41e-05	0.000267	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—uterine cancer	1.4e-05	0.000264	CcSEcCtD
Progesterone—Hypotension—Epirubicin—uterine cancer	1.39e-05	0.000261	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—uterine cancer	1.38e-05	0.000261	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—uterine cancer	1.37e-05	0.000259	CcSEcCtD
Progesterone—Oedema—Doxorubicin—uterine cancer	1.37e-05	0.000259	CcSEcCtD
Progesterone—Infection—Doxorubicin—uterine cancer	1.36e-05	0.000257	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—uterine cancer	1.35e-05	0.000255	CcSEcCtD
Progesterone—Shock—Doxorubicin—uterine cancer	1.35e-05	0.000255	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—uterine cancer	1.35e-05	0.000254	CcSEcCtD
Progesterone—Insomnia—Epirubicin—uterine cancer	1.34e-05	0.000253	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—uterine cancer	1.34e-05	0.000253	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—uterine cancer	1.33e-05	0.000251	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—uterine cancer	1.33e-05	0.000251	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—uterine cancer	1.33e-05	0.00025	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—uterine cancer	1.32e-05	0.000249	CcSEcCtD
Progesterone—Somnolence—Epirubicin—uterine cancer	1.32e-05	0.000249	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—uterine cancer	1.31e-05	0.000247	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—uterine cancer	1.31e-05	0.000246	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—uterine cancer	1.29e-05	0.000243	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—uterine cancer	1.28e-05	0.000242	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—uterine cancer	1.28e-05	0.000242	CcSEcCtD
Progesterone—Fatigue—Epirubicin—uterine cancer	1.28e-05	0.000241	CcSEcCtD
Progesterone—Pain—Epirubicin—uterine cancer	1.27e-05	0.000239	CcSEcCtD
Progesterone—Constipation—Epirubicin—uterine cancer	1.27e-05	0.000239	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.25e-05	0.000236	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—uterine cancer	1.24e-05	0.000234	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—uterine cancer	1.23e-05	0.000232	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—uterine cancer	1.22e-05	0.000231	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—uterine cancer	1.22e-05	0.000231	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—uterine cancer	1.22e-05	0.00023	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—uterine cancer	1.21e-05	0.000229	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—uterine cancer	1.21e-05	0.000228	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—uterine cancer	1.19e-05	0.000225	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.18e-05	0.000224	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—uterine cancer	1.18e-05	0.000223	CcSEcCtD
Progesterone—Urticaria—Epirubicin—uterine cancer	1.18e-05	0.000222	CcSEcCtD
Progesterone—Pain—Doxorubicin—uterine cancer	1.17e-05	0.000221	CcSEcCtD
Progesterone—Constipation—Doxorubicin—uterine cancer	1.17e-05	0.000221	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—uterine cancer	1.17e-05	0.000221	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—uterine cancer	1.17e-05	0.000221	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—uterine cancer	1.13e-05	0.000213	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—uterine cancer	1.12e-05	0.000212	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—uterine cancer	1.09e-05	0.000206	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—uterine cancer	1.09e-05	0.000206	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—uterine cancer	1.08e-05	0.000205	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—uterine cancer	1.08e-05	0.000205	CcSEcCtD
Progesterone—Asthenia—Epirubicin—uterine cancer	1.06e-05	0.000201	CcSEcCtD
Progesterone—Pruritus—Epirubicin—uterine cancer	1.05e-05	0.000198	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—uterine cancer	1.01e-05	0.000191	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—uterine cancer	1.01e-05	0.000191	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—uterine cancer	9.84e-06	0.000186	CcSEcCtD
Progesterone—Dizziness—Epirubicin—uterine cancer	9.81e-06	0.000185	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—uterine cancer	9.71e-06	0.000183	CcSEcCtD
Progesterone—Vomiting—Epirubicin—uterine cancer	9.43e-06	0.000178	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—uterine cancer	9.39e-06	0.000177	CcSEcCtD
Progesterone—Rash—Epirubicin—uterine cancer	9.35e-06	0.000176	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—uterine cancer	9.34e-06	0.000176	CcSEcCtD
Progesterone—Headache—Epirubicin—uterine cancer	9.29e-06	0.000175	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—uterine cancer	9.07e-06	0.000171	CcSEcCtD
Progesterone—Nausea—Epirubicin—uterine cancer	8.81e-06	0.000166	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—uterine cancer	8.72e-06	0.000165	CcSEcCtD
Progesterone—Rash—Doxorubicin—uterine cancer	8.65e-06	0.000163	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—uterine cancer	8.64e-06	0.000163	CcSEcCtD
Progesterone—Headache—Doxorubicin—uterine cancer	8.6e-06	0.000162	CcSEcCtD
Progesterone—Nausea—Doxorubicin—uterine cancer	8.15e-06	0.000154	CcSEcCtD
Progesterone—OPRK1—Signaling Pathways—SMAD3—uterine cancer	2.79e-06	0.000106	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.79e-06	0.000106	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.77e-06	0.000105	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CYP19A1—uterine cancer	2.76e-06	0.000105	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—STK11—uterine cancer	2.76e-06	0.000105	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—RRM2—uterine cancer	2.76e-06	0.000105	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CYP11A1—uterine cancer	2.76e-06	0.000105	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKR1C3—uterine cancer	2.75e-06	0.000105	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—STK11—uterine cancer	2.72e-06	0.000103	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CYP19A1—uterine cancer	2.72e-06	0.000103	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—POLD1—uterine cancer	2.72e-06	0.000103	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKR1C1—uterine cancer	2.7e-06	0.000103	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—POLD1—uterine cancer	2.7e-06	0.000103	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CXCL8—uterine cancer	2.69e-06	0.000102	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—DCN—uterine cancer	2.68e-06	0.000102	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FGFR2—uterine cancer	2.67e-06	0.000101	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—AKT1—uterine cancer	2.65e-06	0.000101	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKR1C3—uterine cancer	2.6e-06	9.9e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—ESR1—uterine cancer	2.59e-06	9.85e-05	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.57e-06	9.77e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCL2—uterine cancer	2.56e-06	9.75e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STK11—uterine cancer	2.56e-06	9.73e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—MTHFR—uterine cancer	2.56e-06	9.73e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.54e-06	9.68e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP11A1—uterine cancer	2.53e-06	9.61e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.52e-06	9.59e-05	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.48e-06	9.45e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—MTHFR—uterine cancer	2.47e-06	9.41e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—RRM2—uterine cancer	2.47e-06	9.38e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—RRM2—uterine cancer	2.41e-06	9.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SOCS3—uterine cancer	2.4e-06	9.11e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—DCN—uterine cancer	2.39e-06	9.1e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKR1C3—uterine cancer	2.39e-06	9.07e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTEN—uterine cancer	2.36e-06	8.97e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—DCN—uterine cancer	2.34e-06	8.88e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—POLD1—uterine cancer	2.3e-06	8.76e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN2B—uterine cancer	2.29e-06	8.72e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ESR1—uterine cancer	2.28e-06	8.67e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—RRM2—uterine cancer	2.27e-06	8.62e-05	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PIK3CA—uterine cancer	2.27e-06	8.62e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.27e-06	8.62e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—STAR—uterine cancer	2.27e-06	8.62e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.25e-06	8.58e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.25e-06	8.57e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—EP300—uterine cancer	2.25e-06	8.55e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—RRM2—uterine cancer	2.25e-06	8.55e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—MTHFR—uterine cancer	2.23e-06	8.48e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IGF1R—uterine cancer	2.23e-06	8.47e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—MTHFR—uterine cancer	2.23e-06	8.47e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—DCN—uterine cancer	2.2e-06	8.37e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP11A1—uterine cancer	2.2e-06	8.37e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—DCN—uterine cancer	2.18e-06	8.3e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.18e-06	8.29e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—NRAS—uterine cancer	2.16e-06	8.2e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.16e-06	8.2e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—STK11—uterine cancer	2.15e-06	8.16e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP19A1—uterine cancer	2.15e-06	8.16e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ERBB2—uterine cancer	2.14e-06	8.13e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.13e-06	8.1e-05	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.1e-06	7.98e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SMAD3—uterine cancer	2.09e-06	7.97e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKR1C3—uterine cancer	2.08e-06	7.9e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—MTHFR—uterine cancer	2.08e-06	7.89e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.07e-06	7.89e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.06e-06	7.82e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—MTHFR—uterine cancer	2.04e-06	7.78e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—STK11—uterine cancer	2.03e-06	7.71e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CYP19A1—uterine cancer	2.03e-06	7.71e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CXCL8—uterine cancer	2.03e-06	7.71e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCL2—uterine cancer	2.01e-06	7.64e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FGFR2—uterine cancer	2e-06	7.6e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—ERBB2—uterine cancer	1.99e-06	7.58e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CDKN1B—uterine cancer	1.98e-06	7.53e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTEN—uterine cancer	1.98e-06	7.51e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.96e-06	7.45e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.94e-06	7.38e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—RRM2—uterine cancer	1.92e-06	7.31e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.9e-06	7.24e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTEN—uterine cancer	1.89e-06	7.2e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—EP300—uterine cancer	1.88e-06	7.17e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—PIK3CA—uterine cancer	1.88e-06	7.14e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CTNNB1—uterine cancer	1.87e-06	7.11e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—DCN—uterine cancer	1.86e-06	7.09e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—STK11—uterine cancer	1.86e-06	7.07e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.86e-06	7.07e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—KRAS—uterine cancer	1.86e-06	7.06e-05	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—AKT1—uterine cancer	1.85e-06	7.04e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—CDKN1B—uterine cancer	1.85e-06	7.02e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTEN—uterine cancer	1.82e-06	6.93e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.81e-06	6.9e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—EP300—uterine cancer	1.81e-06	6.87e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—POLD1—uterine cancer	1.78e-06	6.76e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.76e-06	6.68e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.74e-06	6.63e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—CTNNB1—uterine cancer	1.74e-06	6.63e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EP300—uterine cancer	1.74e-06	6.61e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PIK3CA—uterine cancer	1.7e-06	6.48e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTEN—uterine cancer	1.7e-06	6.46e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ERBB2—uterine cancer	1.67e-06	6.37e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CA—uterine cancer	1.66e-06	6.33e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.66e-06	6.33e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.66e-06	6.33e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.66e-06	6.31e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—STK11—uterine cancer	1.66e-06	6.31e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.66e-06	6.31e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—uterine cancer	1.65e-06	6.26e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRAS—uterine cancer	1.63e-06	6.18e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EP300—uterine cancer	1.62e-06	6.16e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—STK11—uterine cancer	1.62e-06	6.16e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP19A1—uterine cancer	1.62e-06	6.16e-05	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—uterine cancer	1.62e-06	6.14e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—MTHFR—uterine cancer	1.61e-06	6.13e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL8—uterine cancer	1.59e-06	6.04e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—uterine cancer	1.58e-06	6e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.56e-06	5.92e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1B—uterine cancer	1.55e-06	5.9e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—uterine cancer	1.53e-06	5.83e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.53e-06	5.8e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—STK11—uterine cancer	1.53e-06	5.8e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—MTHFR—uterine cancer	1.52e-06	5.79e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—uterine cancer	1.52e-06	5.76e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—STK11—uterine cancer	1.51e-06	5.75e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.51e-06	5.75e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCL2—uterine cancer	1.5e-06	5.72e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.49e-06	5.65e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—RRM2—uterine cancer	1.48e-06	5.64e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—uterine cancer	1.46e-06	5.57e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—DCN—uterine cancer	1.44e-06	5.47e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—uterine cancer	1.43e-06	5.43e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—uterine cancer	1.42e-06	5.41e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.42e-06	5.4e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—uterine cancer	1.4e-06	5.32e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—MTHFR—uterine cancer	1.4e-06	5.31e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—uterine cancer	1.39e-06	5.3e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—uterine cancer	1.39e-06	5.3e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—uterine cancer	1.38e-06	5.23e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EP300—uterine cancer	1.36e-06	5.18e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—uterine cancer	1.36e-06	5.17e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—EP300—uterine cancer	1.36e-06	5.16e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.36e-06	5.16e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.35e-06	5.15e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.34e-06	5.11e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—uterine cancer	1.34e-06	5.08e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—EP300—uterine cancer	1.31e-06	4.99e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—uterine cancer	1.3e-06	4.96e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.29e-06	4.92e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—STK11—uterine cancer	1.29e-06	4.92e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—uterine cancer	1.29e-06	4.9e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—uterine cancer	1.29e-06	4.89e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.28e-06	4.87e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—uterine cancer	1.27e-06	4.84e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—uterine cancer	1.25e-06	4.77e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—MTHFR—uterine cancer	1.25e-06	4.74e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—uterine cancer	1.24e-06	4.73e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—uterine cancer	1.24e-06	4.72e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—uterine cancer	1.24e-06	4.71e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—uterine cancer	1.23e-06	4.68e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.23e-06	4.68e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—MTHFR—uterine cancer	1.22e-06	4.63e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.21e-06	4.61e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—uterine cancer	1.2e-06	4.56e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—uterine cancer	1.19e-06	4.52e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—uterine cancer	1.19e-06	4.52e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—EP300—uterine cancer	1.18e-06	4.5e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—EP300—uterine cancer	1.18e-06	4.49e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1B—uterine cancer	1.16e-06	4.42e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.16e-06	4.4e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—uterine cancer	1.15e-06	4.39e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—MTHFR—uterine cancer	1.15e-06	4.36e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—uterine cancer	1.14e-06	4.33e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—uterine cancer	1.14e-06	4.33e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—MTHFR—uterine cancer	1.14e-06	4.32e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—uterine cancer	1.11e-06	4.22e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—EP300—uterine cancer	1.1e-06	4.19e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.1e-06	4.18e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—uterine cancer	1.1e-06	4.17e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—uterine cancer	1.1e-06	4.17e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—uterine cancer	1.09e-06	4.15e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—EP300—uterine cancer	1.08e-06	4.13e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—uterine cancer	1.07e-06	4.07e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—uterine cancer	1.05e-06	3.99e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EP300—uterine cancer	1.02e-06	3.88e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—uterine cancer	1.01e-06	3.83e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—uterine cancer	1e-06	3.82e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1e-06	3.81e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—STK11—uterine cancer	9.98e-07	3.79e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP19A1—uterine cancer	9.98e-07	3.79e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—uterine cancer	9.79e-07	3.72e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—uterine cancer	9.74e-07	3.71e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—MTHFR—uterine cancer	9.71e-07	3.69e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—uterine cancer	9.71e-07	3.69e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—uterine cancer	9.66e-07	3.67e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—uterine cancer	9.54e-07	3.63e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—uterine cancer	9.48e-07	3.61e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—uterine cancer	9.34e-07	3.55e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—uterine cancer	9.32e-07	3.54e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—uterine cancer	8.97e-07	3.41e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—uterine cancer	8.75e-07	3.33e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—uterine cancer	8.74e-07	3.32e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.56e-07	3.26e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—EP300—uterine cancer	8.55e-07	3.25e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—uterine cancer	8.47e-07	3.22e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—uterine cancer	8.23e-07	3.13e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—uterine cancer	8.21e-07	3.12e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—uterine cancer	8.2e-07	3.12e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—uterine cancer	8.15e-07	3.1e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—EP300—uterine cancer	8.08e-07	3.07e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—uterine cancer	8.02e-07	3.05e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—uterine cancer	7.93e-07	3.02e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—uterine cancer	7.77e-07	2.95e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—uterine cancer	7.55e-07	2.87e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MTHFR—uterine cancer	7.5e-07	2.85e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—EP300—uterine cancer	7.41e-07	2.82e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—uterine cancer	7.3e-07	2.78e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—uterine cancer	7.15e-07	2.72e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—uterine cancer	7.14e-07	2.72e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—uterine cancer	6.98e-07	2.66e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—uterine cancer	6.93e-07	2.64e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—uterine cancer	6.77e-07	2.57e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—uterine cancer	6.66e-07	2.53e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—EP300—uterine cancer	6.61e-07	2.52e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—uterine cancer	6.56e-07	2.49e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—EP300—uterine cancer	6.46e-07	2.46e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—uterine cancer	6.38e-07	2.43e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—uterine cancer	6.33e-07	2.41e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—uterine cancer	6.32e-07	2.4e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—uterine cancer	6.16e-07	2.34e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—EP300—uterine cancer	6.08e-07	2.31e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—EP300—uterine cancer	6.03e-07	2.29e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—uterine cancer	5.98e-07	2.27e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—uterine cancer	5.48e-07	2.08e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—uterine cancer	5.4e-07	2.06e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—uterine cancer	5.17e-07	1.97e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—EP300—uterine cancer	5.15e-07	1.96e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—uterine cancer	4.89e-07	1.86e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—uterine cancer	4.88e-07	1.86e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—uterine cancer	4.78e-07	1.82e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.5e-07	1.71e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—uterine cancer	4.48e-07	1.7e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.46e-07	1.7e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—uterine cancer	4.17e-07	1.59e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—uterine cancer	4e-07	1.52e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—EP300—uterine cancer	3.98e-07	1.51e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—uterine cancer	3.9e-07	1.48e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—uterine cancer	3.81e-07	1.45e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—uterine cancer	3.68e-07	1.4e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—uterine cancer	3.64e-07	1.39e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—uterine cancer	3.11e-07	1.18e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.94e-07	1.12e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—uterine cancer	2.4e-07	9.14e-06	CbGpPWpGaD
